NSETrading Window24 Jun 2026 · 24 Jun 2026, 06:22 pm
Trading Window
Onesource Specialty Pharma Limited · ONESOURCE
✦ AI Summary
Onesource Specialty Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Onesource Specialty Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
ONESOURCECDMO_24062026182227_1_OS_Window_Closure_Q1FY27.pdf
View document text
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi,
560076, India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
Date: June 24, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra Kurla Complex,
Dalal Street, Mumbai- 400001 Bandra (E), Mumbai – 400 051
Scrip Code: 544292 Symbol: ONESOURCE
Dear Madam/ Sirs,
Subject: Intimation regarding closure of Trading Window
Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations,
2015 and Code of Conduct for Prohibition of Insider Trading of OneSource Specialty Pharma Limited (“Company”),
for regulating, monitoring and reporting of trading by insiders, we hereby inform you that the Trading Window for
dealing in shares of the Company shall remain closed from Wednesday, July 01, 2026, until 48 hours after declaration
of the financial results of the Company for the quarter ended June 30, 2026.
The date of the Board Meeting for declaration of financial results of the Company for the quarter ended June 30, 2026,
will be intimated in due course.
Kindly take the above information on record.
For and on behalf of
OneSource Specialty Pharma Limited
Trisha A
Company Secretary and Compliance Officer
Membership Number: A47635
OneSource Specialty Pharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497